本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

2.48
+0.08003.33%
成交量:35.05万
成交额:84.82万
市值:1.50亿
市盈率:-1.12
高:2.51
开:2.40
低:2.25
收:2.40
52周最高:3.05
52周最低:0.8551
股本:6,057.34万
流通股本:3,292.95万
量比:0.69
换手率:1.06%
股息:- -
股息率:- -
每股收益(TTM):-2.2064
每股收益(LYR):-1.7051
净资产收益率:-85.93%
总资产收益率:-42.23%
市净率:1.61
市盈率(LYR):-1.45

数据加载中...

2026/01/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/23

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/21

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/12

重要事件披露

Form 8-K - Current report
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/09

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/08

关联方拟减持公告

Form 144 - Report of proposed sale of securities